| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 04/02/2002 | US6365393 Recombinant virus with an insertion in the hind iii fragment i region; immunomodulators |
| 04/02/2002 | US6365385 Culturing with antioxidant, anticytokine, antiendotoxin and antibiotic; microencapsulating in biocompatible structure having core and semipermeable outer membrane; then incubating in physiological salt to increase capsule durability |
| 04/02/2002 | US6365193 Anti-bacteria agent made from shell, and methods for purifying and desalinating water and for washing agricultural products with use thereof |
| 04/02/2002 | US6365192 Bioactivating substance |
| 04/02/2002 | US6365177 Insulin supplemented infant formula |
| 04/02/2002 | US6365164 Injecting therapeutic amount of botulinum toxin into prostate gland of patient, thereby alleviating symptoms of prostatic hyperplasia, benign prostatic hyperplasia or prostatic enlargement |
| 04/02/2002 | US6365153 Culturing selected cells, plating the cultured cells onto an overlying and an underlying membranes and moving the overlying membrane across the underlaying membrane to stretch and split into two populations connected by elongated cells |
| 04/02/2002 | US6365152 Scours treatment and method of making same |
| 04/02/2002 | US6365148 Spray coating grains; sustained release |
| 04/02/2002 | US6364907 Method to prevent xenograft transplant rejection |
| 03/29/2002 | WO2002066039A1 Anticancer agent |
| 03/28/2002 | WO2002024932A2 Expression vectors containing hybrid ubiquitin promoters |
| 03/28/2002 | WO2002024930A2 Artificial ubiquitous chromatin opening elements (ucoe) |
| 03/28/2002 | WO2002024897A2 Conditionally replicating viral vectors and their use |
| 03/28/2002 | WO2002024891A2 B7-like molecules and uses thereof |
| 03/28/2002 | WO2002024883A2 Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions |
| 03/28/2002 | WO2002024874A2 Methods for preparing interferon producing dentitric cells |
| 03/28/2002 | WO2002024873A1 Stem cell therapy |
| 03/28/2002 | WO2002024640A2 Recombinant adenovirus vectors that are replication-competent in tert-expressing cells |
| 03/28/2002 | WO2002024609A2 Method for producing a radioprotector |
| 03/28/2002 | WO2002024307A2 Reducing the content of particular cell types in a biological sample |
| 03/28/2002 | WO2002024303A1 Blood centrifuge cup having a replaceable compartment for filter support |
| 03/28/2002 | WO2002024224A2 Use of replication-deficient poxvirus vector to boost cd4+ t cell immune response to antigen |
| 03/28/2002 | WO2002024214A2 Use of glp -2 in combination with another therapeutic agent in bone-related and nutrition-related disorders |
| 03/28/2002 | WO2002024211A1 Immunomodulatory preparation |
| 03/28/2002 | WO2002023994A1 A method for limiting the growth of cancer cells using an attenuated measles virus |
| 03/28/2002 | WO2002016554A9 Probiotics products containing lactic acid bacterium |
| 03/28/2002 | WO2002000266A3 A method of treating and preventing infectious diseases |
| 03/28/2002 | WO2001090759A3 Diagnostic method for hyperinsulinism of infancy based on detecting altered k-atp channels |
| 03/28/2002 | WO2001090153A8 Reagents for cell selection and methods of use |
| 03/28/2002 | WO2001085762B1 Cancer diagnosis and assays for screening anti-cancer agents |
| 03/28/2002 | WO2001085182A3 Combined cartilage and plant extract compositions |
| 03/28/2002 | WO2001083692A3 Recombinant aav vectors with aav5 capsids and aav5 vectors pseudotyped in heterologous capsids |
| 03/28/2002 | WO2001077299A3 A METHOD TO PREVENT GRAFT REJECTION USING TGF-β TO INDUCE T SUPPRESSOR CELLS |
| 03/28/2002 | WO2001074859A3 A gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 03/28/2002 | WO2001072279A3 Medical emulsion for lubrication and delivery of drugs |
| 03/28/2002 | WO2001070977A3 Fibroblast growth factor receptor-like molecules and uses thereof |
| 03/28/2002 | WO2001055330A3 Recombinant rhabdoviruses as live-viral vaccines for immunodeficiency viruses |
| 03/28/2002 | WO2001043756A3 Regenerative adjuvant |
| 03/28/2002 | WO2000063241A9 Methods and compositions for modulating an immune response |
| 03/28/2002 | WO2000062833A9 Cellular matrix system and use thereof |
| 03/28/2002 | WO2000060051A3 Arpe-19 as a platform cell line for encapsulated cell-based delivery |
| 03/28/2002 | US20020038150 Injectable implants for tissue augmentation and restoration |
| 03/28/2002 | US20020038017 Synthesis of glycoconjugates of the lewis y epitope and uses thereof |
| 03/28/2002 | US20020037882 Mixture containing glyceride |
| 03/28/2002 | US20020037870 Method of inhibiting cancer cell growth using a vector expressing pRb2/p130 |
| 03/28/2002 | US20020037848 Alzheimer's disease; Parkinson's disease |
| 03/28/2002 | US20020037839 Antiischemic agents; hypotensive agents; antiiflammatory agents |
| 03/28/2002 | US20020037836 Use of GLP for the treatment, prevention, diagnosis, and prognosis of bone-related and nutrition-related disorders |
| 03/28/2002 | US20020037833 Administering botulinium toxin component coupled to substance P |
| 03/28/2002 | US20020037583 Transforming cells with preferfential nucleotide sequences; obtain cells, transform, with vector, express vector, recover preferential proteins |
| 03/28/2002 | US20020037577 Microorganisms for treatment or prevention of corpulence and diabetes mellitus, and pharmaceutical composition containing the same |
| 03/28/2002 | US20020037576 Method of producing infectious reovirus |
| 03/28/2002 | US20020037575 Recombinant virus vectors |
| 03/28/2002 | US20020037566 Apparatus for use in treating in injuries; wound healing agent |
| 03/28/2002 | US20020037549 ABC transport polynucleotides, polypeptides, and antibodies |
| 03/28/2002 | US20020037543 Purging of cells using viruses |
| 03/28/2002 | US20020037341 Food containing active strains for inhibiting infection and treating gastritis, gastric and duodenal ulcers |
| 03/28/2002 | US20020037326 Peptides for inhibiting retroviruses |
| 03/28/2002 | US20020037325 Collecting urine from a mammal, treating with an oxidizing agent in presence of oxygen in container, adding at least one protease, removing substances with a low molecular weight to yield a modified mammal urine |
| 03/28/2002 | US20020037287 For diagnosis and therapy of myeloma and ovarian cancer |
| 03/28/2002 | US20020037282 Universal immunomodulatory cytokine-expressing bystander cell line and related compositions and methods of manufacture and use |
| 03/28/2002 | US20020037281 Methods of transducing neural cells using lentivirus vectors |
| 03/28/2002 | US20020037278 Therapeutic angiogenesis by bone marrow-derived cell transplantation in myocardial ischemic tissue and skeletal muscle ischemic tissue |
| 03/28/2002 | US20020037274 Single agent method for killing tumor and tumor associated endothelial cells using adenoviral mutants |
| 03/28/2002 | US20020037250 Polynucleotides and polypeptides which are diagnostic markers for mammary gland cancer. |
| 03/28/2002 | US20020035997 Method and bottle for infant feeding |
| 03/28/2002 | DE10045935A1 New two-chain protein isolated from Bitis gabonica rhinoceros venom by cation exchange chromatography, useful as specific inhibitor of the intrinsic blood coagulation system |
| 03/28/2002 | DE10045016A1 New retroviral vector, useful e.g. in gene therapy, comprises a foreign sequence between primer binding site and splice donor, has better efficiency of gene expression |
| 03/28/2002 | DE10042710A1 Butter-based dermatological or cosmetic preparation e.g. milking grease, contains essential oil to provide bacteriostatic and/or bactericidal activity and pleasant odor |
| 03/28/2002 | DE10042625A1 Deodorizing apparatus for sewage line, has deodorizing tower with deodorizing layer, catalytic reaction tower with catalyst for reacting catalyst with deodorized gas to form odorless gas |
| 03/28/2002 | DE10042484A1 Preparing human cartilage implants, useful for repairing damaged joints, comprises culturing autologous chondrocytes in alginate gel at reduced oxygen partial pressure |
| 03/28/2002 | DE10042447A1 Protein aus dem Darm von Wirbeltieren, welches Cholesterin absorbiert, sowie Verwendung dieses Proteins zur Identifizierung von Inhibitoren des intestinalen Cholesterintransports Protein from the intestines of vertebrates, which absorbs cholesterol, as well as use of this protein for the identification of inhibitors of intestinal cholesterol transport |
| 03/28/2002 | CA2423082A1 Expression vectors containing hybrid ubiquitin promoters |
| 03/28/2002 | CA2422576A1 Immunomodulatory preparation |
| 03/28/2002 | CA2422544A1 Conditionally replicating viral vectors and their use |
| 03/28/2002 | CA2422215A1 B7-like molecules and uses thereof |
| 03/28/2002 | CA2420160A1 Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions |
| 03/27/2002 | EP1191036A2 Methods and compositions for diagnosing and treating disorders involving angiogenesis |
| 03/27/2002 | EP1191035A2 Three members of the cytokin-receptor class II family |
| 03/27/2002 | EP1190249A2 Compounds and methods to enhance raav transduction |
| 03/27/2002 | EP1190086A2 Genetic modification of male germ cells for generation of transgenic species and genetic therapies |
| 03/27/2002 | EP1190084A1 Regulation system of expression using nuclear ppar receptors |
| 03/27/2002 | EP1190083A2 Dna constructs based on the eif4a gene promoter |
| 03/27/2002 | EP1190082A1 Method of inducing angiogenesis by micro-organs |
| 03/27/2002 | EP1190073A2 Control of gene expression |
| 03/27/2002 | EP1190065A2 Atp binding cassette transporter protein abc1 polypeptides |
| 03/27/2002 | EP1190063A1 Nucleic and proteinic acids corresponding to human gene abc1 |
| 03/27/2002 | EP1190055A2 Human endogenous retrovirus in breast cancer |
| 03/27/2002 | EP1190051A2 Human transport proteins |
| 03/27/2002 | EP1190040A1 Herpes simplex virus expressing foreign genes and method for treating cancers therewith |
| 03/27/2002 | EP1190038A2 Bacterial protection against stress |
| 03/27/2002 | EP1189908A1 Indolocarbazole alkaloids from a marine actinomycete |
| 03/27/2002 | EP1189636A2 A method of treatment of human immunodeficiency diseases |
| 03/27/2002 | EP1189635A1 Autologous adoptive immunotherapy with primed antigen-specific t cells or b cells |
| 03/27/2002 | EP1189632A1 Pneumococcal surface protein combination vaccine |
| 03/27/2002 | EP1189629A2 Methods and reagents for treating glucose metabolic disorders |
| 03/27/2002 | EP1189605A2 High molecular weight primary aliphatic alcohols obtained from beeswax and pharmaceutical use thereof |
| 03/27/2002 | EP1189581A1 Topical anti-microbial compositions |
| 03/27/2002 | EP1155115A4 Method of modifying cytotoxic cells and uses thereof |